Amneal Pharmaceuticals, Inc.

NasdaqGS:AMRX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💊 Pharmaceuticals

Location

United States

Market Cap

USD 2.97 B

Share Price

USD 9.45

Avg Daily Volume

1,625,224

Change (1 day)

0.64%

Change (1 year)

19.47%

Change (YTD)

19.32%

Amneal Pharmaceuticals, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2025: -0.38%

Amneal Pharmaceuticals, Inc. Return on Assets (ROA) is -0.38% for the Trailing 12 Months (TTM) ending March 31, 2025, a -92.00% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Amneal Pharmaceuticals, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2024 was -4.71%, a 29.91% change year over year.
Amneal Pharmaceuticals, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2023 was -3.63%, a 5,546.99% change year over year.
Amneal Pharmaceuticals, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2022 was -0.06%, a -85.09% change year over year.
Amneal Pharmaceuticals, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2021 was -0.43%, a -91.32% change year over year.